LP

LB Pharmaceuticals(LBRX)

NEW YORK, NY
Pharmaceutical

Focus: Schizophrenia Treatments

LB Pharmaceuticals is a life sciences company focused on Schizophrenia Treatments.

NeurologyPsychiatry
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT04588129Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT04187560Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
Phase 1
Phase 2
Clinical Trials (1)
NCT06179108Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
Phase 2
Phase 3
Clinical Trials (1)
NCT0736915452-week Open Label Safety-Tolerability Study
Phase 3
Phase 3
Clinical Trials (1)
NCT07363577Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2014
Portfolio: 5 clinical trials